Treatment of Multiple Cutaneous Leishmaniasis Lesions in Diabetic Patient with Photodynamic Therapy
Treatment of Multiple CL Lesions in Diabetic Patient with PDT
DOI:
https://doi.org/10.66344/jpad.31.4.2021.1755Abstract
Cutaneous leishmaniasis (CL) is the most common type of leishmaniasis. It is originated by different species of the protozoan parasite leishmania, transmitted by infected female sand flies. Although CL is not life-threatening, still may leavequite disfiguring and ugly scars on infected areas. In this case report,we detail the case of asixty-five-year-old diabetic male patient with CL, associated with multiple chronic disfiguring ulcers on foot, ear, leg and arm. The patient was successfully treated with methyl aminolevulinatebased photodynamic therapy (PDT) and after 5 sessions, complete response was achieved.The patient was followed with excellent cosmetic outcome, with no recurrence throughout the observation time and no complication was observed. This study demonstrates the promising role of PDT in the treatment of CL. We have formulated photosensitizer through our institute developed protocol, which increase its efficacy and bring down the medicine cost from US$ 500 to US$ 50.
Downloads
Published
Issue
Section
License
Copyright (c) 2022 Aakifullah Khan, Ghufran Biradar, Karim Khan, Moiz Khan, Javaid Ali
This work is licensed under a Creative Commons Attribution 4.0 International License.
Submission declaration
Authors retain the copyright to their work and grant the 'Journal of Pakistan Association of Dermatologists (JPAD)' the right of first publication under a Creative Commons Attribution 4.0 International (CC BY 4.0) license. This license allows others to share, adapt, and reuse the work for any purpose, including commercial use, as long as appropriate credit is given to the original authors and the journal.
By submitting a manuscript, authors confirm that the work has not been published previously (except as an abstract, lecture, or academic thesis), is not under review elsewhere, and has been approved by all authors and relevant authorities. Once accepted, the article will be openly accessible under the CC BY 4.0 license, ensuring wide dissemination and reuse with proper attribution.
